Yale Jen
Stock Analyst at Laidlaw & Co.
(0.11)
# 4,485
Out of 5,124 analysts
15
Total ratings
6.67%
Success rate
-15.57%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTN Palatin Technologies | Initiates: Buy | $60 | $15.38 | +290.12% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.58 | +1,028.08% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $9.15 | +140.44% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $1.04 | +380.77% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $46.30 | +126.78% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $7.55 | +151.66% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.58 | +1,634.30% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $134.86 | -64.41% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $1.87 | +25,301.07% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $2.34 | +9,515.38% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.34 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.34 | +2,841.18% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.23 | - | 1 | Aug 15, 2023 |
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $15.38
Upside: +290.12%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.58
Upside: +1,028.08%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $9.15
Upside: +140.44%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $1.04
Upside: +380.77%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $46.30
Upside: +126.78%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $7.55
Upside: +151.66%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.58
Upside: +1,634.30%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $134.86
Upside: -64.41%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $1.87
Upside: +25,301.07%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.34
Upside: +9,515.38%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.34
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.34
Upside: +2,841.18%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.23
Upside: -